Brain stimulation and meditation to support attention in older adults with mild cognitive impairment
Tests meditation and gentle brain stimulation on attention in healthy and mildly impaired adults.
Key facts
- Who runs it
- University of Texas at Austin
- Where
- Austin and Georgetown, United StatesSee the 2 sites
- Trial code
- Registry title
- Enhancing Attention in Elderly Using a Brain-Computer-Interface
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 1 Jul 2026
- Expected to end
- 1 Feb 2029
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- transcranial electrical stimulation
- Mindfulness Meditation
- Record updated
- 27 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy younger adults and older adults, including older adults with mild cognitive impairment (MCI). It tests meditation and mild brain stimulation with an EEG-based brain-computer interface.
- Age
- 18 Years to 90 Years
- Sex
- All sexes can join.
- Disease stage
- Older adults must not have a current diagnosis of dementia. Younger adults must be in good general health, with no history of brain or mental illness.
Main reasons for not taking part
- Brain or mental illness that makes brain stimulation (tACS) unsafe, such as epilepsy, seizures, brain damage, fainting, bipolar disorder, schizophrenia or current substance use disorder
- Pacemaker (older adults)
- Medicines that affect seizure risk, such as stimulant medication or high dose bupropion
- Scalp problems that block EEG or stimulation, such as skin infection, wounds or dermatitis
- Diagnosis of dementia, or not able to give informed consent
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Younger adults:
- Good general health
- Normal or corrected vision
- no history of neurological/psychiatric disease
- ability to read and understand English
- ability to understand information and ability to give a free and informed consent; Older adults:
- Normal or corrected vision
- Self-reports no current diagnosis of dementia
- Ability to provide written/electronic, informed consent
Who cannot take part
- Neurological or psychiatric diseases that could be contraindicated for tACS (e.g., personal history of epilepsy/seizure brain damage, history of fainting, bipolar disorder, schizophrenia, current substance use disorder, etc.)
- Medications that elevate seizure threshold (e.g., stimulant medication, high dose bupropion)
- Factors hindering EEG acquisition and tACS delivery (e.g., skin infection, wounds, dermatitis, inability to access the scalp of the participant); Older Adults:
- Neurological or psychiatric diseases that could be contraindicated for tACS (e.g., personal history of epilepsy/seizure brain damage, pacemakers, history of fainting, bipolar disorder, schizophrenia, current substance use disorder, etc.)
- Medications that elevate seizure threshold (e.g., stimulant medication, high dose bupropion)
- Factors hindering EEG acquisition and tACS delivery (e.g., skin infection, wounds, dermatitis, inability to access the scalp of the participant)
- Diagnosis of dementia
- Younger Adults:
- Do not have the capacity to provide informed consent
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
This trial is currently available in United States.
- The University of Texas at AustinAustin, United StatesContact: Jose del R. Millan, PhDTaking people
- Sun CityGeorgetown, United StatesContact: Khushi ThoratTaking people
About the trial
What the trial wants to find out
Cognitive reserve refers to the brain's ability to maintain cognitive performance despite age-related changes or neuropathology. Enhancing cognitive reserve is thought to delay cognitive decline and improve functional outcomes in aging and neurodegenerative conditions. Attention and memory-related neural processes are considered key contributors to cognitive reserve, yet it remains unclear whether these neural markers can be deliberately strengthened through targeted training and non-invasive interventions.
Read full original descriptionShow less
The goal of this clinical study is to investigate whether mindfulness-based meditation and non-invasive brain stimulation can enhance neural markers of attention and memory that serve as proxies for cognitive reserve in cognitively healthy adults and older adults diagnosed with mild cognitive impairment (MCI). Investigators hypothesize that strengthening these neural markers will lead to measurable improvements in cognitive reserve-related functions in both healthy aging and MCI populations.
This study further hypothesizes that neural markers of attention can be selectively enhanced using an electroencephalography (EEG)-based brain-computer interface (BCI) combined with non-invasive interventions such as mindfulness-based relaxation or neuromodulation. During the study, participants will perform a computerized memory task while their EEG signals are recorded in real time. A BCI will analyze these signals to decode the presence or absence of the P300 event-related potential, a well-established neural marker of attentional control and cognitive resource allocation. Real-time feedback and intervention will be used to modulate these neural processes with the goal of promoting adaptive changes in attention-related brain activity.
By integrating EEG-based decoding, behavioral training, and non-invasive interventions, this study aims to determine whether targeted modulation of attention-related neural activity can support cognitive reserve in aging and mild cognitive impairment.
The 4 groups in the trial
- Behavior-based Attention control with MeditationExisting treatment, for comparison
Subjects complete an nback task after a meditation intervention in which ground truth visual feedback is provided at the end of each run.
Treatment: Mindfulness Meditation
- Behavior-based Attention control with Open-Loop tACSExisting treatment, for comparison
Subjects complete an nback task after a tACS intervention in which ground truth visual feedback is provided at the end of each run.
Treatment: transcranial electrical stimulation
- EEG-based Attention Control and MeditationTreatment being tested
Subjects complete an nback task in which EEG-based visual feedback is provided after each trial
Treatment: Mindfulness Meditation
- EEG-Based Attention Control and Open-Loop tACSTreatment being tested
Subjects complete an nback task in which EEG-based visual feedback is provided after each trial
Treatment: transcranial electrical stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Building Cognitive Reserve Through Brain-Computer-Interfaces
- Plain-language title
- Brain stimulation and meditation to support attention in older adults with mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07441122, who can take part
- Record updated
- 27 July 2026